Functional and cytoarchitectural spinal cord protection by ATL-146e after ischemia/reperfusion is mediated by adenosine receptor agonism. 2006

T Brett Reece, and Irving L Kron, and David O Okonkwo, and Jeffrey J Laurent, and Carlos Tache-Leon, and Thomas S Maxey, and Peter I Ellman, and Joel Linden, and Curtis G Tribble, and John A Kern
Department of Surgery, University of Virginia, Charlottesville, VA 22908, USA. tbr5q@virginia.edu

BACKGROUND ATL-146e protects the spinal cord from ischemia/reperfusion injury, presumably via adenosine A(2A) receptor activation, but this relationship remains unproven. We hypothesized that spinal cord functional and cytoarchitectural preservation from ATL-146e would be lost with simultaneous administration of the specific adenosine A(2A) antagonist ZM241385 (ZM), thus proving that adenosine A(2A) receptor activation is responsible for the protective effects of this compound. METHODS New Zealand White rabbits underwent 45 minutes of infrarenal aortic cross-clamping. Groups (n = 10) included sham, ischemia, ischemia plus ATL-146e (ATL-146E), ischemia plus ZM, or ischemia with both compounds (agonist-antagonist). Tarlov scores were recorded every 12 hours. After 48 hours, the spinal cord was fixed for histology and microtubule-associated protein 2 immunohistochemistry. RESULTS Tarlov scores at 48 hours were significantly better in the sham and ATL-146E groups (5.0 and 3.9, respectively) compared with the other three groups (all < or =1.3; P < .001). On hematoxylin and eosin, neuronal viability was higher in the sham, ATL-146E, and agonist-antagonist groups compared with the control and ZM groups (P < .05). Microtubule-associated protein 2 expression was preserved in the sham and ATL-146E groups but was lost in the ATL + ZM, ZM241385, and control groups. CONCLUSIONS ATL-146e preserves the spinal cord in terms of both cytoarchitecture and function after reperfusion of the ischemic spinal cord, but this preservation is not completely blocked by competitive adenosine A(2A) receptor antagonism. Although ATL-146e does seem to partially function through activation of the adenosine A(2A) receptor, the neuroprotective mechanism may not be limited to this particular receptor.

UI MeSH Term Description Entries
D008869 Microtubule-Associated Proteins High molecular weight proteins found in the MICROTUBULES of the cytoskeletal system. Under certain conditions they are required for TUBULIN assembly into the microtubules and stabilize the assembled microtubules. Ensconsin,Epithelial MAP, 115 kDa,Epithelial Microtubule-Associate Protein, 115 kDa,MAP4,Microtubule Associated Protein,Microtubule Associated Protein 4,Microtubule Associated Protein 7,Microtubule-Associated Protein,Microtubule-Associated Protein 7,E-MAP-115,MAP1 Microtubule-Associated Protein,MAP2 Microtubule-Associated Protein,MAP3 Microtubule-Associated Protein,Microtubule Associated Proteins,Microtubule-Associated Protein 1,Microtubule-Associated Protein 2,Microtubule-Associated Protein 3,7, Microtubule-Associated Protein,Associated Protein, Microtubule,E MAP 115,Epithelial Microtubule Associate Protein, 115 kDa,MAP1 Microtubule Associated Protein,MAP2 Microtubule Associated Protein,MAP3 Microtubule Associated Protein,Microtubule Associated Protein 1,Microtubule Associated Protein 2,Microtubule Associated Protein 3,Microtubule-Associated Protein, MAP1,Microtubule-Associated Protein, MAP2,Microtubule-Associated Protein, MAP3,Protein 7, Microtubule-Associated,Protein, Microtubule Associated,Protein, Microtubule-Associated
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D010264 Paraplegia Severe or complete loss of motor function in the lower extremities and lower portions of the trunk. This condition is most often associated with SPINAL CORD DISEASES, although BRAIN DISEASES; PERIPHERAL NERVOUS SYSTEM DISEASES; NEUROMUSCULAR DISEASES; and MUSCULAR DISEASES may also cause bilateral leg weakness. Paralysis, Lower Extremities,Paraplegia, Spastic,Spastic Paraplegia,Paralysis, Legs,Paralysis, Lower Limbs,Paraplegia, Ataxic,Paraplegia, Cerebral,Paraplegia, Flaccid,Paraplegia, Spinal,Ataxic Paraplegia,Ataxic Paraplegias,Cerebral Paraplegia,Cerebral Paraplegias,Flaccid Paraplegia,Flaccid Paraplegias,Paraplegias,Paraplegias, Ataxic,Paraplegias, Cerebral,Paraplegias, Flaccid,Paraplegias, Spastic,Paraplegias, Spinal,Spastic Paraplegias,Spinal Paraplegia,Spinal Paraplegias
D011687 Purines A series of heterocyclic compounds that are variously substituted in nature and are known also as purine bases. They include ADENINE and GUANINE, constituents of nucleic acids, as well as many alkaloids such as CAFFEINE and THEOPHYLLINE. Uric acid is the metabolic end product of purine metabolism.
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D003509 Cyclohexanecarboxylic Acids Carboxylic acid derivatives of cyclohexane. Acids, Cyclohexanecarboxylic
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013116 Spinal Cord A cylindrical column of tissue that lies within the vertebral canal. It is composed of WHITE MATTER and GRAY MATTER. Coccygeal Cord,Conus Medullaris,Conus Terminalis,Lumbar Cord,Medulla Spinalis,Myelon,Sacral Cord,Thoracic Cord,Coccygeal Cords,Conus Medullari,Conus Terminali,Cord, Coccygeal,Cord, Lumbar,Cord, Sacral,Cord, Spinal,Cord, Thoracic,Cords, Coccygeal,Cords, Lumbar,Cords, Sacral,Cords, Spinal,Cords, Thoracic,Lumbar Cords,Medulla Spinali,Medullari, Conus,Medullaris, Conus,Myelons,Sacral Cords,Spinal Cords,Spinali, Medulla,Spinalis, Medulla,Terminali, Conus,Terminalis, Conus,Thoracic Cords

Related Publications

T Brett Reece, and Irving L Kron, and David O Okonkwo, and Jeffrey J Laurent, and Carlos Tache-Leon, and Thomas S Maxey, and Peter I Ellman, and Joel Linden, and Curtis G Tribble, and John A Kern
September 2001, Journal of vascular surgery,
T Brett Reece, and Irving L Kron, and David O Okonkwo, and Jeffrey J Laurent, and Carlos Tache-Leon, and Thomas S Maxey, and Peter I Ellman, and Joel Linden, and Curtis G Tribble, and John A Kern
May 2002, Journal of vascular surgery,
T Brett Reece, and Irving L Kron, and David O Okonkwo, and Jeffrey J Laurent, and Carlos Tache-Leon, and Thomas S Maxey, and Peter I Ellman, and Joel Linden, and Curtis G Tribble, and John A Kern
June 2007, Neurosurgery,
T Brett Reece, and Irving L Kron, and David O Okonkwo, and Jeffrey J Laurent, and Carlos Tache-Leon, and Thomas S Maxey, and Peter I Ellman, and Joel Linden, and Curtis G Tribble, and John A Kern
February 2005, Journal of gastroenterology and hepatology,
T Brett Reece, and Irving L Kron, and David O Okonkwo, and Jeffrey J Laurent, and Carlos Tache-Leon, and Thomas S Maxey, and Peter I Ellman, and Joel Linden, and Curtis G Tribble, and John A Kern
January 2023, Experimental and therapeutic medicine,
T Brett Reece, and Irving L Kron, and David O Okonkwo, and Jeffrey J Laurent, and Carlos Tache-Leon, and Thomas S Maxey, and Peter I Ellman, and Joel Linden, and Curtis G Tribble, and John A Kern
June 2009, Respiratory research,
T Brett Reece, and Irving L Kron, and David O Okonkwo, and Jeffrey J Laurent, and Carlos Tache-Leon, and Thomas S Maxey, and Peter I Ellman, and Joel Linden, and Curtis G Tribble, and John A Kern
April 2005, American journal of physiology. Renal physiology,
T Brett Reece, and Irving L Kron, and David O Okonkwo, and Jeffrey J Laurent, and Carlos Tache-Leon, and Thomas S Maxey, and Peter I Ellman, and Joel Linden, and Curtis G Tribble, and John A Kern
September 2006, Biochemical and biophysical research communications,
T Brett Reece, and Irving L Kron, and David O Okonkwo, and Jeffrey J Laurent, and Carlos Tache-Leon, and Thomas S Maxey, and Peter I Ellman, and Joel Linden, and Curtis G Tribble, and John A Kern
December 2008, Chinese medical journal,
T Brett Reece, and Irving L Kron, and David O Okonkwo, and Jeffrey J Laurent, and Carlos Tache-Leon, and Thomas S Maxey, and Peter I Ellman, and Joel Linden, and Curtis G Tribble, and John A Kern
July 2015, The Annals of thoracic surgery,
Copied contents to your clipboard!